xanthenes has been researched along with Kidney Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, FEM; Azouz, AA; Hersi, F; Hussein Elkelawy, AMM; Omar, HA | 1 |
| Fu, P; Guo, F; Hu, Y; Ma, L; Ren, Q; Tao, S; Wu, C; Yang, L | 1 |
| BARR, LM; BENTINCK-SMITH, J; HYDE, JL | 1 |
| Hartung, T; Jennings, P; Koppelstaetter, C; Morin, JP; Pfaller, W; Ryan, MP | 2 |
| Gupta, PK; Gupta, S; Kataria, M; Lal, J; Muruganandan, S | 1 |
| Cameron, JS | 1 |
| Purchase, IF; van der Watt, JJ | 1 |
8 other study(ies) available for xanthenes and Kidney Diseases
| Article | Year |
|---|---|
Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Calcineurin Inhibitors; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Glutamate-Cysteine Ligase; Kidney Diseases; Male; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Superoxide Dismutase; Tacrolimus; Uric Acid; Xanthenes | 2022 |
Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism.
Topics: Animals; Biological Products; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Fibronectins; Fibrosis; Folic Acid; Histones; Kidney; Kidney Diseases; Mice; RNA, Small Interfering; Transforming Growth Factor beta1; Ureteral Obstruction; Xanthenes; Xanthones | 2022 |
A simple technique for urea nitrogen: the xanthydrol reaction evaluated.
Topics: Blood; Indicators and Reagents; Kidney Diseases; Nitrogen; Urea; Xanthenes | 1956 |
Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 1: technical description.
Topics: Animal Testing Alternatives; Animals; Cell Culture Techniques; Coloring Agents; Culture Media; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Oxazines; Perfusion; Reproducibility of Results; Temperature; Time Factors; Toxicity Tests, Chronic; Xanthenes | 2004 |
Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2: toxicological evaluation.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animal Testing Alternatives; Animals; Cell Culture Techniques; Coloring Agents; Cyclosporine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Humans; Immunosuppressive Agents; Inhibitory Concentration 50; Kidney Diseases; L-Lactate Dehydrogenase; LLC-PK1 Cells; Oxazines; Perfusion; Sodium Dodecyl Sulfate; Surface-Active Agents; Swine; Time Factors; Toxicity Tests, Chronic; Xanthenes | 2004 |
Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats.
Topics: Animals; Antioxidants; Catalase; Chromatography, High Pressure Liquid; Creatine Kinase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glycated Hemoglobin; Heart Diseases; Hypoglycemic Agents; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Myocardium; Proteins; Rats; Rats, Wistar; Superoxide Dismutase; Xanthenes; Xanthones | 2002 |
Uric acid and the kidney.
Topics: Aged; Allopurinol; Animals; Diabetes Mellitus; Gout; Humans; Hydrogen-Ion Concentration; Hypercholesterolemia; Hypertension; Hypoxanthines; Kidney Calculi; Kidney Diseases; Kidney Failure, Chronic; Swine; Uremia; Uric Acid; Xanthenes; Xanthine Oxidase | 1973 |
Acute toxicity of sterigmatocystin to rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dimethylformamide; Female; Injections, Intraperitoneal; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Liver; Liver Diseases; Male; Mycotoxins; Necrosis; Oils; Pharmaceutical Vehicles; Rats; Sex Factors; Xanthenes | 1969 |